Latest Venous thrombosis Stories

DENVER, Dec. 8, 2011 /PRNewswire-USNewswire/ -- Deep vein thrombosis (DVT) is a blood clot in the deep veins in the legs. These clots can break loose and travel to the lungs, causing a potentially fatal pulmonary embolism (PE). Even when they don't, they can cause permanent damage to the leg veins that results in long-term pain, swelling, and disability of the leg. (Logo: <font size="2" face="Arial">http://photos.prnewswire.com/prnh/20110303/DC58830LOGO</font>) Deep...

RICHMOND, Va., Nov. 30, 2011 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.) announced today that medical advisory board member Michael F. Richman M.D., F.A.C.S., founder of the Center for Cholesterol Management and The Elite Laser Vein Center in Los Angeles, has initiated a study that will analyze the relevance of MTHFR polymorphisms in venous disease with or without concomitant thrombosis. It has been reported that a mutation in the gene encoding...

(Ivanhoe Newswire) – Drospirenone-containing oral birth control pills are linked to a significantly higher risk of blood clots, both deep vein thrombosis and pulmonary embolism, according to this study. All oral contraceptives are associated with a higher risk of blood clots, but there is conflicting information about the risk of adverse events with drospirenone. Many previous studies have evaluated risks of second- and third-generation contraceptives, which both contain derivatives of...

The use of drospirenone-containing oral birth control pills is linked to a significantly higher risk of blood clots, both deep vein thrombosis and pulmonary embolism, according to an article in the Canadian Medical Association Journal. All oral contraceptives are associated with a higher risk of blood clots, but there is conflicting information about the risk of adverse events with drospirenone. Many previous studies have evaluated risks of second- and third-generation contraceptives,...

LEXINGTON, Mass., Oct. 20, 2011 /PRNewswire/ -- InaVein, LLC today announced publication of a peer-reviewed paper that examines use of the TRIVEX transilluminated powered phlebectomy (TIPP) System for removal of varicose veins in a clinical office rather than a hospital setting. The paper, Transilluminated Powered Phlebectomy in an Office Setting: Procedural Considerations and Clinical Outcomes was authored by Gregory A. Spitz, M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published...

Patients with inflammatory bowel disease (IBD) undergoing surgery may be more likely to develop deep vein thrombosis (DVT; blood clot in a deep vein in the thigh or leg) or pulmonary embolism (PE; blood clot in blood vessels in the lungs) following surgical procedures, according to a study published Online First by Archives of Surgery, one of the JAMA/Archives journals. "An increased risk of DVT and PE in patients with IBD has been evident for the past 75 years," the authors write as...

Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous thromboembolism (VTE), a dangerous, often life-threatening condition, according to study results published today in Blood, the Journal of the American Society of Hematology (ASH).Recent studies have shown that patients diagnosed with SVT using ultrasound to confirm the...

A new risk prediction tool can identify patients at high risk of serious blood clots who might need preventative treatment, according to a study published on bmj.com.The tool, which can be found at www.qthrombosis.org, is based on simple variables which the patient is likely to know and could be easily integrated into GP computer systems to risk assess patients prior to hospital admission, long haul flights, or starting medications that carry an increased clotting risk.The condition, known as...

(Ivanhoe Newswire) -- Siblings of those who have been hospitalized with potentially lethal blood clots in the legs or pelvis are more likely to also suffer the disorder than those with healthy siblings, according to this study.The Swedish study is the first to show a direct correlation between venous thromboembolism (VTE) and family risk in a nationwide setting, sorted by age and gender.VTE consists of deep vein thrombosis (DVT), which typically involves blood clots that form in the deep...

TOKYO, July 19, 2011 /PRNewswire/ -- Building on its cardiovascular portfolio, Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), is proud to announce the launch of LIXIANA® (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) in Japan. This announcement follows the first marketing approval for edoxaban 15 mg and 30 mg tablets by the Japanese Ministry of Health, Labor and Welfare in April 2011 (1), and marks the first time edoxaban is commercially available to patients in any global...